Pephexia Therapeutics ApS — Credit Rating and Financial Key Figures

Pephexia Therapeutics ApS (CVR number: 41319208) is a company from FREDERIKSBERG. The company recorded a gross profit of -3212.1 kDKK in 2023. The operating profit was -6013.3 kDKK, while net earnings were -5439.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was -34.6 %, which can be considered poor and Return on Equity (ROE) was -72.5 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -70.6 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Pephexia Therapeutics ApS's liquidity measured by quick ratio was 4.5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.